- Lobbying
- Lobbying by Circassia Pharmaceuticals, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Mike Merola | Deputy CoS, Sen. Torricelli |
Rob Zucker | LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg |
Nancy Fox | Staff Director House Appropriations Committee, Chief of Staff Rep. Rodney Frelinghuysen (NJ) Scheduler Rep. Marge Roukema (NJ), Scheduler Rep. Silvio O. Conte (MA) |
Molly McDonnell | LC/LA/Senior Health Policy Advisor; Congressman Leonard Lance |
Charla Penn | LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd |
Robert Zucker | LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Registration
Issue(s) they said they’d lobby about: Drug Pricing Legislation.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate